Compare EYE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYE | BHVN |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2017 | 2022 |
| Metric | EYE | BHVN |
|---|---|---|
| Price | $18.81 | $15.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $31.22 | $29.08 |
| AVG Volume (30 Days) | 2.3M | ★ 3.6M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 202.78 | 26.08 |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $1,987,488,000.00 | N/A |
| Revenue This Year | $5.56 | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $47.47 | ★ N/A |
| Revenue Growth | ★ 9.00 | N/A |
| 52 Week Low | $14.75 | $7.48 |
| 52 Week High | $30.02 | $18.57 |
| Indicator | EYE | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 55.54 | 73.82 |
| Support Level | $14.84 | $14.83 |
| Resistance Level | $19.18 | $15.71 |
| Average True Range (ATR) | 0.95 | 0.99 |
| MACD | 0.36 | 0.36 |
| Stochastic Oscillator | 87.86 | 81.19 |
National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.